A GPT-4o-powered AI system enhances early-stage ovarian cancer diagnosis using pelvic CT exams.
Key Details
- 1Study published in Annals of Surgical Oncology; team led by Shimin Zhang, MD.
- 2GPT-4o trained to identify four key CT features linked to ovarian cancer malignancy.
- 3Dataset included 479 patients with confirmed benign or early malignant ovarian lesions.
- 4AI achieved diagnostic accuracies of 80.8%, 79.1%, and 93.3% across lesion identification, feature recognition, and malignancy status, respectively.
- 5Clinician reliability ratings for AI detection: 4.2–4.3 out of 5 across key features.
- 6AI assistance improved diagnosis accuracy for gynecologic oncologists (from 67.9% to 78.1%).
Why It Matters
This approach could reduce diagnostic variability and support less experienced clinicians by improving the consistency and accuracy of CT-based ovarian cancer diagnosis. Earlier detection enables better patient outcomes and survival rates.
Source
AuntMinnie
Related News
•Radiology Business
Study Highlights Limitations of AI in Prostate MRI Screening
New research points to several shortcomings in implementing AI for MRI-based prostate cancer screening.
•AuntMinnie
Deep Learning Model Predicts Brain Tumor MRI Enhancement Without Gadolinium
German researchers developed a deep learning approach to predict MRI contrast enhancement in brain tumors without the need for gadolinium-based agents.
•Radiology Business
SimonMed Imaging Introduces Paid AI Add-Ons for Routine Exams
SimonMed Imaging is launching new AI-powered elective services for routine imaging exams with additional out-of-pocket costs for patients.